期刊文献+

结直肠腺癌中神经内分泌细胞微卫星改变和p53基因突变的检测 被引量:4

Detection and clinicopathologic significance of microsatellite alteration and p53 mutation ofneuroendocrine cells in colorectal adenocarcinoma
原文传递
导出
摘要 目的通过检测结直肠腺癌中神经内分泌(NE)细胞微卫星改变和p53基因突变,探讨结直肠腺癌中NE细胞的克隆性起源。方法采用激光捕获显微切割(LCM)技术,应用DNA抽提和全基因组扩增,在全基因组范围内选取26个微卫星位点,使用聚合酶链反应-单链构象多态性(PCR—SSCP)-银染色检测30例伴NE分化的结直肠腺癌中腺癌细胞和NE细胞的微卫星不稳定(MSI)、杂合性缺失(LOH)改变情况,联合PCR测序检测p53基因突变发生情况。结果30例样本MSI总发生率为16.9%,LOH总发生率为8.5%,腺癌细胞与NE细胞的MSI和LOH发生率差异无统计学意义。30例样本中6例微卫星改变完全一致,23例微卫星改变一致性大于不一致性,1例微卫星改变一致性与不一致性相同。微卫星改变一致性与不一致性的差异有统计学意义(t=11.138,P=0.000)。053基因突变发生率为16.7%,腺癌细胞与NE细胞发生一致性改变。结论结直肠腺癌中腺癌细胞与NE细胞具有相似的微卫星改变和完全一致的p53基因突变,推测两种细胞起源具有一致性。 Objective To study the possible clonal origin of neuroendocrine cells in eoloreetal adenocarcinoma. Methods Twenty-six microsatellite loci were screened using laser capture mierodissection, DNA extraction and whole genome amplification. Mierosatellite instability (MSI) and loss of heterozygosity (LOH) in adenoearcinoma cells and neuroendocrine ceils amongst 30 cases of colorectal carcinoma with neuroendocrine differentiation were detected using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) -silver staining. The mutation status of p53 was evaluated by PCRsequencing. The elonal origin of neuroendocrine cells in colorectal adenoearcinoma was determined. Results Amongst the 30 cases studied, the prevalence of MSI was 16.9% while that of LOH was 8.5%. The rate showed no statistically significant difference between adenocarcinoma cells and neuroendocrine cells. In 6 cases, the microsatellite alteration was entirely consistent. In 23 cases, the rate of mierosatellite alteration consistency was greater than that of inconsistency. In l case, the consistency and inconsistency rates were identical. There was statistically significant difference between consistency and inconsistency of microsatellite alteration. The prevalence of p53 mutation was 16. 7% which was the same for both adenocarcinoma cells and neuroendocrine cells. Conclusions Adenocarcinoma ceils and neuroendocrine cells in coloreetal adenocarcinoma with neuroendocrine differentiation have similar biologic changes. It is likely that they are of identical origin.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2013年第1期10-14,共5页 Chinese Journal of Pathology
基金 浙江省自然科学基金(Y2110133) 浙江省医药卫生科学研究基金计划(2010KYA060)
关键词 结直肠肿瘤 杂合子丢失 微卫星不稳定性 基因 p53 Colorectal neoplasms Loss of heterozygosity Microsatellite instability Genes, p53
  • 相关文献

参考文献2

二级参考文献34

  • 1[1]Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G.Neuroendocrine differentiation in carcinomas of the breast:a study of 51 cases. Semin Diagn Pathol 1989; 6:174-188 被引量:1
  • 2[2]Van Laarhoven HA, Gratama S, Wereldsma JC. Neuroendocrine carcinoid tumours of the breast: a variant of carcinoma with neuroendocrine differentiation. J Surg Oncol 1991; 46:125-132 被引量:1
  • 3[3]Giovanella L, Marelli M, Ceriani L, Giardina G, Garancini S,Colombo L. Evaluation of chromogranin A expression in serum and tissues of breast cancer patients. Int J Biol Markers 2001; 16:268-272 被引量:1
  • 4[4]Kimura N, Sasano N, Yamada R, Satoh J. Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour. Virchows Arch A Pathol Anat Histopathol 1988; 413:33-38 被引量:1
  • 5[5]Kimura N, Hoshi S, Takahashi M, Takeha S, Shizawa S, Nagura H. Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors. J Urol 1997; 157:565-568 被引量:1
  • 6[6]Portel-Gomes GM, Grimelius L, Johansson H, Wilander E,Stridsberg M. Chromogranin A in human neuroendocrine tumors:an immunohistochemical study with region-specific antibodies.Am J Surg Pathol 2001; 25:1261-1267 被引量:1
  • 7[7]Bernini GP, Moretti A, Ferdeghini M, Ricci S, Letizia C, D′Erasmo E, Argenio GF, Salvetti A. A new human chromogranin ′A′immunoradiometric assay for the diagnosis of neuroendocrine tumours. Br J Cancer 2001; 84:636-642 被引量:1
  • 8[8]Yao GY, Chen PH, Lai MD, Hong LY. Study of 9 neuroendocrine markers in pancreatic tumors. Zhenjiang Yike Daxue Xuebao 1995;24:56-58 被引量:1
  • 9[9]Chen FX, Corti A, Siccardi AG. DIBIT; San Raffaele H.Characterizzation of antigenic sites of Human Chromogranin A.Shanghai Mian Yixue Zazhi 1998; 18:215-219 被引量:1
  • 10[10]di Sant′Agnese PA. Neuroendocrine differentiation in prostatic carcinoma: an update. Prostate Suppl 1998; 8:74-79 被引量:1

共引文献13

同被引文献31

  • 1陈斌,雷秀霞,周小棉.高分辨率熔解曲线技术及其在分子诊断中的应用进展[J].分子诊断与治疗杂志,2009,1(2):120-124. 被引量:15
  • 2杜明,丰有吉.DHPLC和DDF检测散发性卵巢癌p53基因突变的应用[J].中国临床医学,2006,13(1):108-111. 被引量:5
  • 3何松,严桥,陈旭东,张建兵,陆晓云,潘宏佳,陈莉.胃癌细胞中神经内分泌分化与术后生存关系的研究[J].中国肿瘤临床,2007,34(22):1283-1286. 被引量:11
  • 4García-Yuste M,Matilla JM,González-Aragoneses F. Neuroendocrine tumors of the lung[J].{H}Current Opinion in Oncology,2008,(2):148-154. 被引量:1
  • 5Kl(o)ppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms[J].{H}Endocrine Related Cancer,2011,(Suppl 1):S1-S16. 被引量:1
  • 6Lewin KJ. The endocrine cells of the gastrointestinal tract.The normal endocrine cells and their hyperplasias.Part Ⅰ[J].{H}PATHOLOGY ANNUAL,1986,(Pt 1):1-27. 被引量:1
  • 7Grabowski P,Schindler I,Anagnostopoulos I. Neuroendocrine differentiation is a relevant prognostic factor in stage Ⅲ-Ⅳ colorectal cancer[J].{H}European Journal of gastroenterology & hepatology,2001,(4):405-411. 被引量:1
  • 8Shinji S,Naito Z,Ishiwata T. Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis[J].{H}International Journal of Oncology,2006,(2):357-364. 被引量:1
  • 9Cho YB,Yang SS,Lee WY. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer[J].Int J Surg Patho1,2010,(3):201-206. 被引量:1
  • 10Volante M,Rindi G,Papotti M. The grey zone between pure (neuro)endocrine and non-(neuro) endocrine tumours:a comment on concepts and classification of mixed exocrine-endocrine neoplasms[J].{H}VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2006,(5):499-506. 被引量:1

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部